|Title||Short-term costs of preeclampsia to the United States health care system.|
|Publication Type||Journal Article|
|Year of Publication||2017|
|Authors||Stevens W, Shih T, Incerti D, Ton TGN, Lee HC, Peneva D, Macones GA, Sibai BM, Jena AB|
|Journal||Am J Obstet Gynecol|
|Date Published||2017 09|
|Keywords||Adult, Bronchopulmonary Dysplasia, Cerebral Hemorrhage, Cohort Studies, Female, Fetal Distress, Gestational Age, Health Care Costs, Humans, Infant, Infant, Newborn, Leukomalacia, Periventricular, Male, Middle Aged, Postpartum Hemorrhage, Pre-Eclampsia, Pregnancy, Regression Analysis, Respiratory Distress Syndrome, Newborn, Retrospective Studies, Seizures, Sepsis, Thrombocytopenia, United States, Young Adult|
BACKGROUND: Preeclampsia is a leading cause of maternal morbidity and mortality and adverse neonatal outcomes. Little is known about the extent of the health and cost burden of preeclampsia in the United States.
OBJECTIVE: This study sought to quantify the annual epidemiological and health care cost burden of preeclampsia to both mothers and infants in the United States in 2012.
STUDY DESIGN: We used epidemiological and econometric methods to assess the annual cost of preeclampsia in the United States using a combination of population-based and administrative data sets: the National Center for Health Statistics Vital Statistics on Births, the California Perinatal Quality Care Collaborative Databases, the US Health Care Cost and Utilization Project database, and a commercial claims data set.
RESULTS: Preeclampsia increased the probability of an adverse event from 4.6% to 10.1% for mothers and from 7.8% to 15.4% for infants while lowering gestational age by 1.7 weeks (P < .001). Overall, the total cost burden of preeclampsia during the first 12 months after birth was $1.03 billion for mothers and $1.15 billion for infants. The cost burden per infant is dependent on gestational age, ranging from $150,000 at 26 weeks gestational age to $1311 at 36 weeks gestational age.
CONCLUSION: In 2012, the cost of preeclampsia within the first 12 months of delivery was $2.18 billion in the United States ($1.03 billion for mothers and $1.15 billion for infants), and was disproportionately borne by births of low gestational age.
|Alternate Journal||Am J Obstet Gynecol|